Study of NMS-03305293 in Pts With Selected Advanced/Metastatic Solid Tumors
Condition(s):Advanced/Metastatic Solid TumorsLast Updated:March 18, 2022Unknown status
Hide Studies Not Open or Pending
Condition(s):Advanced/Metastatic Solid TumorsLast Updated:March 18, 2022Unknown status
Condition(s):Acute Myeloid Leukemia (AML); Chronic Myelomonocytic Leukemia (CMML)Last Updated:February 21, 2024Recruiting
Condition(s):Advanced Solid TumorsLast Updated:September 7, 2012Terminated
Condition(s):Glioblastoma; Diffuse GliomaLast Updated:March 15, 2024Recruiting
Condition(s):Advanced/Metastatic Solid TumorsLast Updated:September 7, 2012Terminated
Condition(s):Advanced or Metastatic Solid TumorsLast Updated:September 7, 2012Completed
Condition(s):Unresectable Hepatocellular Carcinoma (HCC)Last Updated:February 28, 2024Active, not recruiting
Condition(s):Parkinson’s DiseaseLast Updated:June 16, 2015Completed
Condition(s):Advanced Parkinson’s DiseaseLast Updated:November 28, 2023Completed
Condition(s):Rhabdomyolysis; Myopathy; Acute Renal Failure; Neuroleptic Malignant SyndromeLast Updated:December 1, 2009Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.